New York, NY, June 21, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Regenerative Medicines Market by Therapy (Tissue Engineering, Cell Therapy, Immunotherapy, and Gene Therapy), by Material (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials, and Others), and by Application (Oncology, Orthopedic and Musculoskeletal Spine, Cardiovascular, Dermatology, Central Nervous System, Diabetes, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024” . According to the report, global regenerative medicines market was valued at approximately USD 7.97 billion in 2017 and is expected to generate revenue of around USD 26.30 billion by the end of 2024, growing at a CAGR of around 18.59% between 2017 and 2024.
Regenerative medicines include the process of regenerating human cells, organs, and tissues to restore its normal function. They have the capability to regenerate damaged tissues and whole organ by replacing damaged tissue and organ. Sometimes, regenerative medicines also stimulate the repair mechanism of the body to heal its organ or tissue. Scientists use this to grow tissues and organs in the laboratory to implant them in the body when it is unable to heal itself.
Browse through 66 Tables & 32 Figures spread over 110 Pages and in-depth TOC on "Global Regenerative Medicines Market: Industry Size, Share, Trends, Growth Analysis, and Forecast, 2017 - 2024”.
Request Free Sample Report of Global Regenerative Medicines Market Report @ https://www.zionmarketresearch.com/sample/reg...nes-market
The global regenerative medicines market is segregated on the basis of therapy, material, and application. On the basis of therapy, the market is segmented into tissue engineering, cell therapy, immunotherapy, and gene therapy. Cell therapy segment is expected to dominate the regenerative medicines market due to its rapid growth in the use of stem cells for grafting and organ generation techniques. The materials segment is divided into synthetic materials, biologically derived materials, genetically engineered materials, and others. Biologically derived materials are expected to dominate the regenerative medicines market but genetically engineered materials are expected to show high growth due to increase in the use of various genetic engineering techniques such as gene sequencing and editing technology. The application segment includes oncology, orthopedic and musculoskeletal spine, cardiovascular, dermatology, central nervous system, diabetes, and other applications. Dermatology segment is expected to dominate the regenerative medicines market due to the use of various stem cells in injuries and chronic wounds.
North America is anticipated to lead the global regenerative medicines market in the forecast period. Rise in the number of organ transplantation and rise in need of research in various application domains such as oncology, orthopedic musculoskeletal spine, and cardiovascular diseases have fueled the market growth of the regenerative medicines in North America. The rapid increase in investment for the development of the regenerative medicine by various companies and rapid uptake of this developed technology by population is also expected to fuel the growth of regenerative medicines market in this region. Presence of major market players in this region is also expected to fuel the growth of regenerative medicine market.
Download Free Report Brochure: https://www.zionmarketresearch.com/requestbro...nes-market
Europe is expected to grow at a significant growth rate. Growing prevalence of various diseases such as diabetes, cancer, bone- and joint-related diseases, etc. and technological advancements in the stem cell technology has driven the demand for the regenerative medicines in the European region. Increasing awareness about the regenerative medicines in the population has also driven the growth of the regenerative medicines market in this region.
The Asia Pacific is expected to show high growth rates over the forecast period in the global regenerative medicines market. Presence of flexible regulatory environment for clinical adoption and rapid advancement in stem cell research for cell-based regenerative therapy has mainly driven the regenerative medicine market in the Asia Pacific. Also, investments by the government and private companies to support the development of novel approaches in countries such as China, Japan, and India and availability of well-developed infrastructure and research facilities are aspects expected to boost the growth of regenerative medicines market in the Asia Pacific. Also, the increase in investments in healthcare research by emerging economies is expected to fuel the growth of the regenerative medicines market in this region.
Browse the full "Regenerative Medicines Market by Therapy (Tissue Engineering, Cell Therapy, Immunotherapy, and Gene Therapy), by Material (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials, and Others), and by Application (Oncology, Orthopedic and Musculoskeletal Spine, Cardiovascular, Dermatology, Central Nervous System, Diabetes, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/reg...nes-market
The Middle East and Africa and Latin America are expected to witness a slow growth in the forecast period. Rise in the number of organ transplantation cases, growth in demand for tissue-engineered products, and increasing healthcare expenditure is expected to drive the growth of regenerative medicines market in these regions.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/re...nes-market
The key players in the global regenerative medicines market are Acelity, Celgene Corporation, NuVasive, Inc., Vericel Corporation (Genzyme), StemCells, Inc., Japan Tissue Engineering Co., Ltd., Anika Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Inc., Medtronic, Inc., and Arthrex, Inc. The players are frequently involved in developing new therapies in regenerative medicines.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/823
This report segments the global regenerative medicines market as follows:
Global Regenerative Medicines Market: Therapy Segment Analysis
- Tissue Engineering
- Cell Therapy
- Immunotherapy
- Gene Therapy
Global Regenerative Medicines Market: Material Segment Analysis
- Synthetic Materials
- Biologically Derived Materials
- Genetically Engineered Materials
- Others
Global Regenerative Medicines Market: Application Segment Analysis
- Oncology
- Orthopedic and Musculoskeletal Spine
- Cardiovascular
- Dermatology
- Central Nervous System
- Diabetes
- Other Applications
Global Regenerative Medicines Market: Regional Segment Analysis
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Equine Healthcare Market: https://www.zionmarketresearch.com/report/equ...are-market
- Monoclonal Antibody Therapeutics Market: https://www.zionmarketresearch.com/report/mon...ics-market
- Flow Cytometry Market: https://www.zionmarketresearch.com/report/flo...try-market
- Batten Disease Treatment Market: https://www.zionmarketresearch.com/report/bat...ent-market
- Scar Treatment Market: https://www.zionmarketresearch.com/report/sca...ent-market
- Heparin Market: https://www.zionmarketresearch.com/report/heparin-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us
Contact Us:
Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com
